These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7198424)

  • 1. [Experimental study of sulpiride-bromocriptine association on the female rat estrous cycle (author's transl)].
    Valli M; Bruguerolle B; Jadot G; Bouyard P
    Ann Endocrinol (Paris); 1981; 42(1):49-55. PubMed ID: 7198424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bromocriptine and progesterone on the length of the ovarian cycle in 4- and 5-day estrous cyclic rats.
    Sánchez-Criado JE; van der Schoot P
    Rev Esp Fisiol; 1989 Sep; 45(3):235-8. PubMed ID: 2616870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prolactin, bromocriptine and sulpiride on estrogen and lactogenic receptors in the rat adrenal gland.
    Lüthy IA; Chiauzzi VA; Charreau EH; Calandra RS
    Acta Physiol Pharmacol Latinoam; 1984; 34(1):15-23. PubMed ID: 6089499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A physiological role for sporadic interruptions of the dopaminergic tone in the genesis of big mass prolactin pulses.
    López FJ; Sánchez-Criado JE; Negro-Vilar A
    Endocrinology; 1991 Sep; 129(3):1471-80. PubMed ID: 1874184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinemia-induced precocious puberty in the female rat: ovarian site of action.
    Advis JP; Ojeda SR
    Endocrinology; 1978 Sep; 103(3):924-35. PubMed ID: 570498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrous cycle lengthening by pentobarbital in the rat: prolactin involvement.
    Geiger JM; Boehm N; Aron C
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):199-203. PubMed ID: 3389052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Four benzamides (metoclopramide, sulpiride, sultopride and tiapride) effects on the oestrus cycle of the female rat: a comparative statistical study (author's transl)].
    Bruguerolle B; Jadot G; Valli M; Bouyard L; Fabregou-Bergier P; Perrot J; Bouyard P
    J Pharmacol; 1981; 12(1):27-36. PubMed ID: 7194403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between hypothalamic dopaminergic and opioidergic systems in the photoperiodic regulation of pulsatile luteinizing hormone secretion in sheep.
    Tortonese DJ
    Endocrinology; 1999 Feb; 140(2):750-7. PubMed ID: 9927302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine and sulpiride competitively inhibit estrogen binding to its receptor in the adrenal gland.
    Lüthy IA; Calandra RS
    Experientia; 1986 Feb; 42(2):136-8. PubMed ID: 3948967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of bromocriptine on the pressor responses to afferent nervous stimulation.
    Montastruc JL; Gaillard-Plaza G; Montastruc P
    J Pharmacol; 1984; 15(2):169-76. PubMed ID: 6738075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinstatement of estrous cycles in middle-aged spontaneously persistent estrous rats: importance of circulating prolactin and the resulting facilitative action of progesterone.
    Everett JW
    Endocrinology; 1980 Jun; 106(6):1691-6. PubMed ID: 6102903
    [No Abstract]   [Full Text] [Related]  

  • 12. Bromocriptine-induced blockade of pregnancy affects sleep patterns in rats.
    Zhang SQ; Kimura M; Inoué S
    Neuroimmunomodulation; 1996; 3(4):219-26. PubMed ID: 9094443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in nalorphine-induced hyperprolactinaemia after bromocriptine or sulpiride administration.
    Barreca T; Magnani G; Sannia A; Rolandi E
    Eur J Clin Pharmacol; 1982; 22(4):375-6. PubMed ID: 7106173
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine inhibits salsolinol-induced prolactin release in male goats.
    Hashizume T; Sawada T; Nakajima Y; Yaegashi T; Saito H; Goto Y; Jin J; Fülöp F; Nagy GM
    Anim Sci J; 2012 Jan; 83(1):63-7. PubMed ID: 22250741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cyclic AMP in the action of dopaminergic D2 receptors of some endocrine glands in rats.
    Abu-Jayyab A; el-Denshary EE; Ageel AM; Dakkak MR
    Biosci Rep; 1987 Oct; 7(10):751-5. PubMed ID: 2833951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep and local field potential effect of the D2 receptor agonist bromocriptine during the estrus cycle and postpartum period in female rats.
    Tóth A; Keserű D; Pethő M; Détári L; Bencsik N; Dobolyi Á; Hajnik T
    Pharmacol Biochem Behav; 2024 Jun; 239():173754. PubMed ID: 38537873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A trophoblast-specific factor(s) suppresses circulating prolactin levels and increases tyrosine hydroxylase activity in tuberoinfundibular dopaminergic neurons.
    Arbogast LA; Soares MJ; Tomogane H; Voogt JL
    Endocrinology; 1992 Jul; 131(1):105-13. PubMed ID: 1351837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of maternal exposure to the galactagogue Sulpiride on reproductive parameters in female rats.
    de Azevedo Camin N; Vieira ML; Montagnini BG; Kiss AC; Gerardin DC
    Physiol Behav; 2015 Mar; 140():247-53. PubMed ID: 25554483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrous cycle modification of rat mammary tumor induction by a single dose of N-methyl-N-nitrosourea.
    Ratko TA; Beattie CW
    Cancer Res; 1985 Jul; 45(7):3042-7. PubMed ID: 4039975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of anestrus in rats treated with an antihypertensive agent, losulazine hydrochloride.
    Mesfin GM; Johnson GA; Higgins MJ; Morris DF
    Toxicol Appl Pharmacol; 1987 Jan; 87(1):91-101. PubMed ID: 3099429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.